No charge unless you’re prescribed.

No charge unless you’re prescribed.

Legal

Consent to Telehealth

Effective date: July 23, 2026

Your consent to receive clinical services through the Rila telehealth platform.

Entity: BJE Equity LLC, doing business as Rila

Website: joinrila.com

1. What Telehealth Is

Telehealth is the delivery of clinical care using electronic information and communication technology, where the patient and the treating clinician are in different physical locations. A telehealth encounter may include the exchange of medical intake information, the transmission of images or laboratory results, real-time audio and video consultation, the issuance of a prescription where clinically appropriate, and follow-up communication through secure messaging. This Telehealth Informed Consent (the "Consent") explains the ways clinical care is delivered through the Rila platform, the expected benefits and potential risks of that mode of delivery, and your rights and responsibilities as a patient. By checking the acceptance box during enrollment and continuing to a consultation, you confirm that you have read and agreed to this Consent.

2. Parties to This Consent

Rila ("Rila," "we," "us," or "our") is a technology platform, operated by BJE Equity LLC, that coordinates non-clinical administrative, technology, and support services. Rila does not practice medicine, is not a pharmacy, and is not a party to the clinician-patient relationship. Clinical services are delivered by independently licensed healthcare professionals ("Providers") who exercise independent professional judgment. Medications prescribed through the platform are dispensed by independent, licensed pharmacies ("Partner Pharmacies"). Each Provider will be licensed in the state in which you are located at the time of the consultation and will exercise independent clinical judgment in accordance with applicable law.

3. Electronic Transmissions Used in Your Care

The following categories of electronic transmission may occur during your care through the platform:

  • Account creation, identity verification, and appointment scheduling.

  • Completion, exchange, and review of medical intake forms and health history.

  • Secure transmission and clinical review of photographs, video, laboratory results, and other clinically relevant information.

  • Synchronous two-way video, two-way audio, or two-way audio with store-and-forward communications during a consultation.

  • Asynchronous secure messaging between you and your Provider or care team.

  • Issuance of clinical recommendations, diagnosis notes, treatment plans, and prescriptions where clinically appropriate.

  • Prescription refill reminders, follow-up prompts, and clinical check-ins.

  • Other transmissions reasonably necessary for the provision of your clinical care.

4. Expected Benefits

  • Improved access to care by allowing you to be evaluated from your home or another preferred location.

  • Convenient follow-up communication through the secure messaging feature of the platform.

  • More efficient evaluation, treatment planning, and care management for conditions that can be appropriately addressed by telehealth.

  • Reduced time and cost associated with travel to in-person appointments.

5. Potential Risks and Limitations

Telehealth differs from in-person care in several ways that you should understand before consenting to treatment.

  • No physical examination. Your Provider cannot physically examine you. Some conditions require hands-on evaluation or in-person diagnostic testing; where this is the case, your Provider will advise you and may decline to prescribe or may refer you for in-person care.

  • Technology failure. Internet interruptions, device issues, or service outages may delay, interrupt, or prevent a consultation. Alternative arrangements will be offered when practical.

  • Image or data quality. If transmitted information is of inadequate quality for clinical assessment, your Provider may reschedule the consultation or recommend in-person care.

  • Security. Although the platform uses industry-standard safeguards, no electronic system is fully immune to interception, misrouting, or unauthorized access. Messages and attachments sent outside the platform, for example by unencrypted email or text, are more vulnerable than those sent within it.

  • Not for emergencies. The platform is not designed for medical emergencies. If you are experiencing an emergency, including severe symptoms, suicidal ideation, or imminent risk of harm, call 911 or go to the nearest emergency department immediately; do not rely on platform messaging.

  • Local primary care remains important. Telehealth is a supplement to, not a substitute for, an ongoing relationship with a local primary care provider. You are encouraged to maintain a primary care provider.

6. Patient Acknowledgments

By consenting to telehealth care through the platform, you acknowledge and agree that:

  • I will be given an opportunity to be connected to an available Provider, and I have been, or will be, provided information sufficient to identify the Provider and verify that the Provider is licensed in my state of residence.

  • If I am experiencing a medical emergency, I will call 911 or go to the nearest emergency department. I understand that Rila and my Provider are not able to connect me to local emergency services through the platform.

  • I may decline telehealth and seek services from a clinician with in-person availability as an alternative.

  • I have the right to withhold or withdraw consent to telehealth at any time without affecting my right to seek future care or treatment.

  • Federal and state laws protect the confidentiality and security of my health information. I am entitled to the full privacy protections afforded by those laws. Records of my telehealth encounter are part of my medical record.

  • My health information may be electronically transmitted to other licensed clinicians or entities involved in my care, which may be located in other states.

  • My personally identifiable images or information will not be shared with researchers or educational institutions without my separate affirmative consent.

  • I accept the risk of technology or equipment failure during a telehealth visit, which may cause delay in evaluation or loss of information, and I release my Provider and Rila from liability for delays or information loss attributable to such failures, to the fullest extent permitted by law.

  • Certain services associated with my care, such as laboratory testing or blood draws, may be performed at another location, for example a commercial laboratory, collection site, or at-home kit, at my Provider's direction.

  • A person other than my Provider may be present during a telehealth visit to operate the telehealth technology. I will be informed of any such person's presence and role. I may omit personally sensitive details, ask nonclinical personnel to leave, and/or terminate the consultation at any time.

  • My Provider will explain any diagnosis or recommended treatment and the risks and benefits of available options. I have the opportunity to ask questions before deciding whether to proceed.

  • I may request a copy of my medical records by emailing team@joinrila.com or by using the secure messaging function in the platform. Rila operates the team@joinrila.com inbox solely as administrative support and routes records requests to my Provider, who maintains the medical record. My Provider will respond within the timeframes required by applicable law. A reasonable fee for copying, shipping, and delivery may apply as permitted by law.

  • There is no guarantee that I will be issued a prescription. Whether a prescription is clinically appropriate is my Provider's independent determination. If a prescription is issued, I may have it filled at the pharmacy engaged through the platform or, where applicable, at a pharmacy of my choice.

  • I consent to receive invitations, appointment notifications, clinical reminders, and related communications from my Provider and Rila via email, in-platform message, automated telephone dialing systems, prerecorded or artificial voice messages, and, where I have separately opted in, text messages. I will promptly notify Rila of any change to my contact information.

  • I understand that I may receive multiple messages per day, that standard message and data rates may apply, and that automated messages and unsecured email or text communications may not be encrypted end-to-end. I may opt out of non-clinical automated communications at any time, consistent with our SMS Policy and Privacy Policy, without affecting my eligibility for care.

  • Rila and my Provider use reasonable physical, technical, and administrative safeguards to protect the privacy of my personal information. I understand the limitations of unencrypted email and text and may request alternative communication methods by contacting team@joinrila.com.

7. Not for Emergencies

The Rila platform and the clinicians who provide care through it do not furnish emergency medical services. If you are experiencing a medical emergency — including severe chest pain, difficulty breathing, signs of stroke, severe allergic reaction, suicidal thoughts, or any condition you believe is life-threatening — call 911 or proceed immediately to the nearest emergency department. In a mental health crisis, you may also call or text 988 to reach the Suicide and Crisis Lifeline.

8. Financial Disclosures and the Federal Open Payments Program

The federal Physician Payments Sunshine Act requires drug, device, and biologic manufacturers and group purchasing organizations to report certain payments and transfers of value made to physicians and teaching hospitals. Reported information is publicly searchable on the federal Open Payments database maintained by the Centers for Medicare & Medicaid Services (CMS) at openpaymentsdata.cms.gov. This disclosure is provided for informational purposes only. Neither this disclosure nor the existence of any payment on the Open Payments database establishes any conflict of interest or improper conduct by your Provider.

9. Withdrawal of Consent

You may withdraw your consent to telehealth at any time by notifying your Provider through secure messaging or by emailing team@joinrila.com. Withdrawal of consent does not affect care already provided and does not by itself cancel any scheduled medication shipment or recurring subscription; see our Refund Policy and Terms of Service for how those matters are handled.

10. State-Specific Disclosures

The disclosures below apply to patients who reside in or receive care while located in the states identified. Each state imposes its own combination of records-sharing rights, complaint-filing notices, and other patient-rights disclosures. Where a state in which you receive care is not specifically listed, the general protections described in Sections 1 through 9 apply.

10.1 Alaska: Alaska residents have the right to receive a copy of their telehealth encounter records and to share those records with their primary care physician. Complaints about an Alaska-licensed clinician may be filed with the Alaska Division of Corporations, Business and Professional Licensing, which oversees the State Medical Board.

10.2 Connecticut: Connecticut residents have the right to share copies of their telehealth encounter records with their primary care physician.

10.3 Florida: Florida residents are entitled to the protections set forth in the Florida Patient's Bill of Rights and Responsibilities, codified at Florida Statutes § 381.026.

10.4 Iowa: Complaints about an Iowa-licensed clinician may be filed with the Iowa Board of Medicine.

10.5 Idaho: Complaints about an Idaho-licensed clinician may be filed with the Idaho Board of Medicine through its consumer complaint portal.

10.6 Indiana: Complaints about an Indiana-licensed clinician may be filed with the Indiana Professional Licensing Agency through its public file-a-complaint portal.

10.7 Kansas: Kansas law provides that, where a Kansas patient designates a primary care or treating physician, a report of the telemedicine encounter shall be sent to that physician within three (3) days of the patient's consent to such report. If you are a Kansas resident with a primary care or treating physician you wish to share records with, please provide that clinician's name, practice, and contact information at intake or by secure message following your visit.

10.8 Kentucky: Complaints about a Kentucky-licensed clinician may be filed with the Kentucky Board of Medical Licensure through its grievances page.

10.9 Maine: Complaints about a Maine-licensed allopathic (M.D.) clinician may be filed with the Maine Board of Licensure in Medicine. Complaints about an osteopathic (D.O.) clinician may be filed with the Maine Board of Osteopathic Licensure.

10.10 New Hampshire: New Hampshire residents have the right to receive copies of their telehealth encounter records and to share those records with their primary care physician or treating provider.

10.11 Ohio: Ohio residents have the right to share copies of their telehealth encounter records with their primary care physician.

10.12 Oklahoma: Complaints about an Oklahoma-licensed allopathic (M.D.) clinician may be filed with the Oklahoma State Board of Medical Licensure and Supervision. Complaints about an osteopathic (D.O.) clinician may be filed with the Oklahoma State Board of Osteopathic Examiners.

10.13 Rhode Island: Complaints about a Rhode Island-licensed clinician may be filed with the Rhode Island Department of Health through its complaints page.

10.14 South Carolina: South Carolina residents have the right to control the distribution of their medical records. With your consent, your medical records may be distributed to other treating health care practitioners in accordance with applicable laws and regulations.

10.15 Texas: Under Texas law, with your consent, a copy of your medical records from the telehealth encounter may be transmitted to your primary care physician within seventy-two (72) hours of the encounter. If you would like your records shared with a named primary care physician, please provide that clinician's name, practice, and contact information during your intake or by secure message following the visit. If you have not designated a primary care physician, no records will be shared under this provision.

Notice Concerning Complaints: Complaints against physicians and other licensees and registrants of the Texas Medical Board — including physician assistants, acupuncturists, and surgical assistants — may be reported for investigation to the Texas Medical Board at: Texas Medical Board, Attention: Investigations, 333 Guadalupe, Tower 3, Suite 610, P.O. Box 2018, MC-263, Austin, Texas 78768-2018. Telephone: 1-800-201-9353. Website: www.tmb.texas.gov.

10.16 Vermont: Vermont residents have the right to receive a real-time consultation with the distant-site provider, either at the time of the initial consult or within a reasonable time thereafter. Receiving telehealth services through Rila does not preclude you from receiving real-time telemedicine or in-person services with your Provider at a future date (Vt. Stat. Ann. § 9361). Complaints about a Vermont-licensed clinician may be filed with the Vermont Board of Medical Practice or with the Vermont Board of Osteopathic Examiners.

11. Acknowledgment

By checking the acceptance box at enrollment and proceeding to a consultation, you acknowledge that you have read this Telehealth Informed Consent, that you have had the opportunity to ask questions, and that you voluntarily consent to receive care via telehealth on the terms described above. A copy of this Consent is available at joinrila.com and upon request to team@joinrila.com.

Rila is a telehealth platform that connects patients with independent, US-licensed healthcare providers. Rila does not provide medical care or prescribe medication; all care decisions are made by independent providers. Prescriptions are issued only after an online consultation and only if a provider determines treatment is appropriate. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Individual results vary; weight-loss outcomes are based on clinical studies of GLP-1 medications combined with diet and exercise. This website does not offer medical advice — consult a qualified healthcare provider with any questions about a medical condition. If you are experiencing a medical emergency, call 911.

Medical provider partners

We are partnered with DrTelx (drtelx.com), an independent telehealth medical group whose providers are licensed in the states where we offer care. We work exclusively with licensed U.S. pharmacies that meet rigorous regulatory and quality standards. Our pharmacy partners include EPIQ Scripts, Foothills Professional Pharmacy, and Emerald Pharmacy. Every pharmacy in our network is licensed in the states where it dispenses, accredited by the National Association of Boards of Pharmacy (NABP), board-certified, and LegitScript-approved. All prescriptions are filled and shipped by these licensed U.S. pharmacies in compliance with applicable state and federal law.

States served

Our telehealth services are available to patients located in all 50 U.S. states and the District of Columbia. All consultations are conducted by licensed U.S. healthcare providers, and all prescriptions are dispensed by licensed U.S. pharmacies. Treatment is only provided where clinically appropriate and permitted by applicable state and federal law. Availability of specific medications may vary by state based on state regulations and provider licensure. Asynchronous (online questionnaire) care is available in the following 44 states: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KY, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WY. A live (synchronous) consultation with a provider is required before treatment in these 7 jurisdictions: District of Columbia (DC), Kansas (KS), Louisiana (LA), Mississippi (MS), New Mexico (NM), Rhode Island (RI), West Virginia (WV).

Important safety information

The assessment made available on the Rila website does not create a doctor-patient relationship between the individual completing the assessment and Rila. Rila, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Rila assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and a Rila clinician will meet with an individual after checkout to determine if they qualify for a prescription. Rila clinicians retain the decision to prescribe compounded GLP-1s to patients.


All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire and every 3-4 weeks thereafter. Results from compounded medications found on the Rila platform may vary and be affected by an individual’s adherence to the program and their clinician’s recommendations. Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider’s medical judgment, which is informed by a telehealth consultation and medical history.


We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Rila does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.

Ozempic®, Wegovy®, Mounjaro® & Zepbound® are trademarks of their respective owners.

© 2026 Rila. All rights reserved.